Drugs / A/H5N1 Inactivated, split-virion pandemic influenza vaccine
A/H5N1 Inactivated, split-virion pandemic influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00491985 | Jun 2007 → Dec 2009 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H5N1 Inactivated, split-virion pandemic influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00491985 ↗ |
| Modality | Vaccine | “influenza A/H5N1 vaccine” PMID 19112513 ↗ Dec 2008 |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00491985 ↗ |